Updates

• 16 November 2021

  Inequitable Access to COVID-19 Tools is Hindering the Pandemic Response

  A new snapshot reveals the persistent and glaring inequity in access to lifesaving COVID-19 tools, such as diagnostic tests, treatments (including medical oxygen), and personal protective equipment (PPE), that is hindering the pandemic response in lo...
• 03 November 2021

  Briefing Note: Testing for both Tuberculosis and SARS-CoV-2

  The new Briefing Note on Testing for both Tuberculosis and SARS-CoV-2 is now available, also in French and Spanish. It provides information for TB programs including testing for both diseases.
• 03 September 2021

  Accelerating Procurement of Approved Health Products under C19RM - COVID-19 Response Mechanism

  Principal Recipients are requested to accelerate the procurement of approved health products under C19RM awards through both Pooled Procurement Mechanism (PPM) and non-PPM channels to ensure rapid availability in their countries.
• 17 August 2021

  The ACT-Accelerator: Diagnostics Pillar Update

  Testing is the first line of defense in the fight against COVID-19. Without testing, countries cannot track or contain the spread of the virus, address urgent clinical needs, test the efficacy of vaccines, or detect the emergence of new variants.
• 10 August 2021

  Protecting Health Care Workers With Personal Protective Equipment (PPE): Working Paper

  Access to medical personal protective equipment (PPE) is essential for delivering health care. It can reduce the risk of infection during a pandemic by an estimated 60-95% and is one of the most cost-effective health interventions.
• 20 May 2021

  Scaling up COVID-19 Diagnostics using Antigen Rapid Diagnostic Tests (Ag RDTs)